Here, we established lenvatinib‐resistant HCC cell lines, patient‐derived organoids, and xenografts models, and identified that the significant upregulation of HECTD2 was closely associated with resistance to lenvatinib. Here, HECTD2 is linked to hepatocellular carcinoma.